We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
11 Jul 23
The CONVINCE Trial study compares high-dose hemodiafiltration with standard, high-flux hemodialysis. Study revealed a 23% decrease in mortality…
11 Jul 23
With the publication of the final results from the LOW-PV study in the New England Journal of Medicine…
11 Jul 23
Results from ALPHA Phase III trial demonstrated statistically significant increase compared to placebo in mean hemoglobin from baseline…
11 Jul 23
Medtronic plc (NYSE:MDT), a global leader in medical technology, today announced its participation in the upcoming American Diabetes…
11 Jul 23
Developed in collaboration with nurses and therapists to help ease the burden on critical care teams. Supports care…
11 Jul 23
Medtronic plc(opens new window) (NYSE: MDT), a global leader in healthcare technology, is presenting a robust collection of…
11 Jul 23
Abiomed, part of Johnson & Johnson MedTech[1], announces results of a third-party analysis showing that utilizing Impella during…
06 Jun 23
UHG, through its health services unit Optum, has offered to pay $100 in cash per Amedisys share, which…
Jamie Bell takes a look at life expectancy rates by country — from the five major European markets…
We take a look over the timeline followed by the novel coronavirus outbreak that has triggered a global…